Our work showed that the expression of Shh signaling pathway components such as Shh, Gli1, and Smo in primary MDS stromal cells (n = 23) was significantly increased and positively correlated with IPSS risk types of MDS. The gene discussed is SMO; the disease is myelodysplastic syndrome.